Page last updated: 2024-09-04

sg 209 and 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one

sg 209 has been researched along with 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one in 1 studies

Compound Research Comparison

Studies
(sg 209)
Trials
(sg 209)
Recent Studies (post-2010)
(sg 209)
Studies
(1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one)
Trials
(1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one)
Recent Studies (post-2010) (1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one)
15037930110

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Girolamo, N; Heywood, GJ; Thomas, PS; Wei, XM1

Other Studies

1 other study(ies) available for sg 209 and 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one

ArticleYear
Nicorandil inhibits the release of TNFalpha from a lymphocyte cell line and peripheral blood lymphocytes.
    International immunopharmacology, 2003, Volume: 3, Issue:12

    Topics: B-Lymphocytes; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyburide; Herpesvirus 4, Human; Humans; Immunoglobulin G; Leukocytes, Mononuclear; Niacinamide; Nicorandil; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Oxadiazoles; Pinacidil; Potassium Channels; Quinoxalines; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha

2003